North America Medical Isolation Gowns Market Overview and Growth by 2028

The medical isolation gowns market in North America is expected to grow from US$ 518.34 million in 2021 to US$ 1,385.93 million by 2028; it is estimated to grow at a CAGR of 15.1% from 2021 to 2028.

 Patients acquire hospital-acquired infections or healthcare-associated infections (HAIs) while receiving health services in a hospital or any other healthcare facility. Common pathogens, such as bacteria, viruses, fungi, and parasites, cause these infections. HAIs include catheter-associated urinary tract infections, surgical site infections (SSI), central line-associated bloodstream infections, ventilator-associated pneumonia, hospital-acquired pneumonia, and several other infections. Many surgical devices can act as HAI spreaders as well.  Isolation gowns are mandatory to use during any medical procedures in healthcare facilities. They help prevent cross-contamination, transfer of body fluids, and any infection-causing microorganisms and penetration of liquids. Government agencies, such as the National Healthcare Safety Network (NHSN) of the Center for Disease Control and Prevention (CDC), closely monitor the infections that help prevent HAI and enhance patient safety. In the US, the Department of Health and Human Services (HHS) works toward reducing HAI cases. For instance, a survey, titled “awareness of HAIs amongst medical students in a tertiary care center,” reported that a total of 82% (out of 250) students were aware of HAIs. Due to the increasing awareness, robust preventative measures, and the implementation of infection surveillance measures in hospital settings, the prevalence of HAIs is reducing significantly. Therefore, it is established that the rise in awareness regarding HAIs is increasing the demand for medical isolation gowns substantially across the region, leading to an upward thrust in the market’s growth.

The COVID-19 pandemic outbreak was first observed in December 2019 in Wuhan (China), and it has spread to ~100 countries across the world, with the World Health Organization (WHO) stating it as a public health emergency. In the North American region, the US was profoundly affected by the outbreak of the COVID-19 pandemic. The country has marked the highest number of positive patients. Across the nation, various healthcare research centers were working only for research on COVID 19 therapeutics. Additionally, during the initial phase of the COVID-19 crisis, due to lockdown and supply chain disruptions, the demand for Medical Isolation Gowns was disrupted owing to a change in customer behaviors. As the problem moved forward, healthcare professionals realized that developing novel therapies using innovative technologies is essential to mitigate this unprecedented crisis. In the middle of this situation, governments around the world were not prepared for such a pandemic. There is no definitive treatment against COVID 19 has been established. Medical isolation gowns are among the highly consumed hospital consumables. The hospitals utilize a larger quantity of medical isolation gowns during the COVID19 pandemic and for general patients. There has been an immense rise in the demand for medical isolation gowns in the regions. To overcome this shortage, regulatory agencies such as USFDA have given revised guidelines regarding surgical gowns. The agency has also liberalized the product approval procedures to facilitate early product availability in the market. Various market players of non-healthcare businesses are taking involvement in the medical isolation gowns' productions to fulfill the high demand. The existing players are ramping up the production and supply chain for the medical isolation gowns in the region. For instance, Ferrara Manufacturing, located in New York City's historic Fashion District, has been producing Olympic uniforms for Team USA, runway garments, and formal suiting for several major luxury brands since 1987. In March 2020, however, Ferrara Manufacturing shifted its garment production from high-end fashion to medical isolation gowns for the frontline worker. Also, Accel Unite had recently developed a new design for reusable isolation gowns. Dow collaborated with nine key partners across various industries to develop and donate 100,000 isolation gowns to help frontline workers in Texas, Louisiana, and Mexico. Thus, new players' innovative product development is expected to create healthy market competition in the North American medical isolation gowns market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the medical isolation gowns market. The North America medical isolation gowns is expected to grow at a good CAGR during the forecast period.

 North America Medical Isolation Gowns Market Revenue and Forecast to 2028 (US$ Million)

North America Medical Isolation Gowns Market Segmentation

North America Medical Isolation Gowns Market – By Type

• Disposable
• Reusable

North America Medical Isolation Gowns Market – By Product Type

• Surgical
• Non-Surgical

North America Medical Isolation Gowns Market – By End User

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

North America Medical Isolation Gowns Market- By Country

• US
• Canada
• Mexico

North America Medical Isolation Gowns Market-Companies Mentioned

• Advin Health Care
• Alsco, Inc.
• Cardinal Health, Inc.
• Medline Industries, Inc.
• Mölnlycke Health Care AB
• Narang Medical Limited.
• SARA HEALTH CARE
• STANDARD TEXTILE CO., INC

North America Medical Isolation Gowns Report Scope